Oruka Therapeutics Inc. (ORKA)
NASDAQ: ORKA
· Real-Time Price · USD
19.79
0.61 (3.18%)
At close: Oct 03, 2025, 3:59 PM
19.40
-1.97%
After-hours: Oct 03, 2025, 05:53 PM EDT
3.18% (1D)
| Bid | 19 |
| Market Cap | 741.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 19.91 |
| Volume | 281,365 |
| Avg. Volume (20D) | 263,977 |
| Open | 19.13 |
| Previous Close | 19.18 |
| Day's Range | 19.06 - 19.86 |
| 52-Week Range | 5.49 - 31.13 |
| Beta | -0.33 |
| Ex-Dividend Date | n/a |
About ORKA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORKA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORKA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 days ago
+26.91%
Oruka Therapeutics shares are trading higher. BTIG...
Unlock content with
Pro Subscription
2 weeks ago
+8.79%
Oruka Therapeutics shares are trading higher after the company announced interim Phase 1 results for ORKA-001. Also, the company announced a $180 million private placement.